|
This report is linked to mfg report numbers: (same patient - different events)
3013886523-2025-00216
3013886523-2026-00195
study - biomarin cerliponase alfa observational study
"on an unspecified date, the participant underwent implantation of intracerebroventricular device (icv) set (codman rickman icv device; model number 82-1623).The lot number was not reported."
"on (b)(6) 2017, the participant was initiated on treatment with brineura (300 milligram, qow, intracerebroventricular use).The lot number for brineura was m006590.The most recent dose was administered on 03-jul-2026."
"on (b)(6) 2019, the participant again had an icv set implanted."
"on (b)(6) 2026 at 08:22, the participant experienced grade 1 device related infection.Prior to the infusion, on (b)(6) 2026, the participant's csf culture was obtained.On (b)(6) 2026, preliminary results of the culture indicated cuti bacterium (formerly propionibacterium) acnes in thioglycolate broth only.On (b)(6) 2026, final results of the csf culture indicated cuti bacterium (formerly propionibacterium) acnes in thioglycolate broth only.The outcome of the event was reported as recovering/resolving.
|